2017 Sep;12(6):853-859. doi: 10.1007/s11739-016-1497-4.  BJones  BMHockings Although many patients with atrial fibrillation experience relief of symptoms with control of the heart rate, some patients require restoration of sinus rhythm. When the article failed to make concealment methods explicit and the author failed to provide adequate clarification, we assumed concealment was inadequate.  GOlshansky  SJanuary  Deds.Montori No randomized placebo-controlled studies have been done to determine if a single oral dose of amiodarone may work as effectively.POPULATION STUDIED: Patients older than 18 years were eligible … We measured agreement and resolved disagreement by consensus.The reviewers also identified duplicate or updated publications and contacted the authors to clarify uncertainty about originality of data. Mean time for conversion overall was 385 mins in group ibutilide and 495 mins in group amiodarone …  et al. For a study with a 33% control event rate, the highest possible RR is 3; for a control event rate of 80%, the highest possible RR is 1.25, even if the treatment event rate is 100%.  HMaciejewicz  AKNanas On the other hand, experimenting with a wide variety of thresholds runs the substantial risk for capitalizing on the play of chance and identifying apparent subgroup differences that do not really exist. The mean conversion time with amiodarone was reported to be ranging from 224 to 414 minutes, 4, 18, 19, 26 which was consistent with the median time to conversion of 410 minutes in our study.  RLSegal Methodological quality  GQPiepoli Amiodarone rated 5.0/10 vs Dronedarone rated 6.3/10 in … Statistical analysis Although it appears likely that amiodarone is safe when used in the short-term setting for the conversion of AF to sinus rhythm, one would require studies with more detailed exploration of AEs to provide a definitive conclusion.Our review has some limitations. The efficacy reported is 34-69% with the bolus only regimens, and 55-95% with the bolus followed by infusion regimens. It is similar in structure to amiodarone with the addition of a methylsufonamide group and absence of iodine moieties.  EBMiller BACKGROUND: Amiodarone, a class III antiarrhythmic agent, is effective in the conversion of AF to sinus rhythm.  WBLevy This difference allows more rapid metabolism and a lower likelihood of side effects.  DJGuyatt  GCook References 2. It is an iodinated compound but is metabolized by plasma and tissue esterases rather than the CYP3A4 system.  MMinder  G Duration of AF proved to be a source of heterogeneity, leading to 2 analyses.  DVaziri 2003 Feb;87(2-3):121-8. doi: 10.1016/s0167-5273(02)00467-9.Cybulski J, Kułakowski P, Budaj A, Danielewicz H, Maciejewicz J, Kawka-Urbanek T, Ceremuzyński L.Clin Cardiol. Citations that 1 reviewer considered relevant were further assessed independently by 2 of us (L.M.L.  SHKlingenheben  et al. RCT indicates randomized controlled trial.Relative risk for conversion to sinus rhythm. doi: 10.1016/s0167-5273(02)00477-1.  TCMiller  GHRyan  TBoriani Unable to load your collection due to an error  HEMarketou Egger Intravenous amiodarone in treatment of recent-onset atrial fibrillation.  BJones COVID-19 is an emerging, rapidly evolving situation. Clinicians frequently pre-treat patients with amiodarone to increase the efficacy of electrical cardioversion for atrial fibrillation (AF). Efficacy of agents for pharmacologic conversion of atrial fibrillation and subsequent maintenance of sinus rhythm. We found one such review that addressed the efficacy and safety of different antiarrhythmic drugs compared with placebo, digoxin, or calcium channel blockers (CCBs) in conversion of nonpostoperative AF to sinus rhythm.We included studies that met the following criteria: (1) Patients had AF of any etiology and duration; (2) The intervention consisted of amiodarone compared with placebo, digoxin, CCB, or no treatment (control group); (3) The primary outcome consisted of conversion to sinus rhythm during a period of 4 weeks or less; and (4) The design consisted of randomized or quasi-randomized clinical trials.We included published and unpublished studies without language restriction.